PBMs Still In Prosecutors’ Sights; Express Scripts Faces Spitzer
Executive Summary
New York Attorney General Eliot Spitzer's suit against Express Scripts represents another high-profile challenge to the pharmacy benefit management business model at a time when the industry hopes to play a prominent role in the Medicare drug benefit
You may also be interested in...
PBMs Will Emerge From “Regulatory Cloud” Soon, Express Scripts Predicts
The investigations of pharmacy benefit management practices will take up to three more years to resolve, Express Scripts CFO Edward Stiften predicted during the Bear Stearns conference in New York Sept. 13
PBMs Will Emerge From “Regulatory Cloud” Soon, Express Scripts Predicts
The investigations of pharmacy benefit management practices will take up to three more years to resolve, Express Scripts CFO Edward Stiften predicted during the Bear Stearns conference in New York Sept. 13
J&J Is Spitzer’s Next Target: New York AG Opens Broad Off-Label Investigation
Johnson & Johnson is responding to a request from the New York Attorney General for information about marketing practices for its six largest prescription drug brands